The effectiveness of atomoxetine with Ritalin and fluoxetine on anxiety, the severity of attention deficit hyperactivity disorder, and the performance of children with ADHD - Attention Deficit Hyperactivity Disorder

Phase 2

Recruiting

• Conditions: Attention Deficit Hyperactivity Disorder and Anxiety Disorders.; Attention-deficit hyperactivity disorders + Phobic anxiety disorders; F90+F40

• Registration Number: IRCT20211004052670N2
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Students 6 to 12 years old referred to Khorshid Psychiatric Clinic, and Amin
Attention Deficit Hyperactivity Disorder and Anxiety Disorder based on DSM-5 Primary age (6 to 12 years)

Exclusion Criteria

Having any chronic illness
Family history of psychosis and mood disorder in the family first degree

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of Anxiety Disorders. Timepoint: Before the intervention, 1 and 4 months after the start of the intervention. Method of measurement: The child and parent Screen for Child Anxiety Related Emotional Disorders (SCARED).;Severity of Attention Deficit Hyperactivity Disorder. Timepoint: Before the intervention, 1 and 4 months after the start of the intervention. Method of measurement: Conners' Continuous Performance Test.;Performance score. Timepoint: Before the intervention, 1 and 4 months after the start of the intervention. Method of measurement: The Child Anxiety Impact Scale (CAIS).